Résultats de votre recherche

Michael Drake - Director - a reçu un Doctor of Medicine in Ophthalmology de University of California, San Francisco.

Andrew Plump - Director and President, Research & Development - has a Medical Doctorate from University of California, San Francisco and PhD Biolog from Rockefeller University.

Geoffrey Duyk - Director - has a post-doctoral training in Medical Science from University of California, San Francisco and Doctor of Philosophy & Master of Science from Case Western Reserve University.

Geoffrey Duyk - Director - has a post-doctoral training in Medical Science from University of California, San Francisco and Doctor of Philosophy & Master of Science from Case Western Reserve University.

Annie Tsong - Chief Strategy, Product and Ingredients Officer - has a PhD in Genetics from University of California, San Francisco and Bachelor of Biochemistry from Harvard University.

Sara Kenkare-Mitra - President and Head of Research and Development - a reçu un PhD in Biopharmaceutical Sciences de University of California, San Francisco.

Nate Gosse - Vice President, Project Management - has a PhD in Developmental Biology from University of California, San Francisco and Bachelor in Biology and Computer Science from Washington University in St. Louis.

Casey Lynch - Managing Director, Business Services, Healthcare, Consumer - has a Master of Science in Neuroscience from University of California, San Francisco and Bachelor of Science in Neuroscience from University of California, Los Angeles.

Brad Youngblood - Head of Research & Pre-Clinical Development - has a Postdoctoral Fellowship from University of California, San Francisco and PhD in Cell, Cellular and Molecular Biology from Texas Tech University Health Sciences Center.

Joanne Beck - Director - has a Postdoctoral, Biochemistry and Molecular Biology from University of California, San Francisco and PhD Biochemistry and Molecular Biology from Oregon Health and Science University.

Aaron Tward - Chief Scientific Officer - has a Doctor of Medicine from University of California, San Francisco and Master of Arts in Microbiology and Molecular Genetics from University of California, Los Angeles.

Leonard Dragone - Chief Medical Officer - has a Pediatric Rheumatology Fellowship Degree from University of California, San Francisco and Bachelor of Science in Biochemistry from University of Rochester.

Joanne Beck - Chief Technology Officer - has a Postdoctoral, Biochemistry and Molecular Biology from University of California, San Francisco and PhD Biochemistry and Molecular Biology from Oregon Health and Science University.

Fady Malik - Executive Vice President, Research and Development - has a Fellowship in Interventional Cardiology Program from University of California, San Francisco and Fellowship in Cardiovascular Disease Program from University of California, San Francisco.

Bill Martin - Managing Director - has a Postdoc, Neuroscience from University of California, San Francisco and PhD in Experimental Psychology from University of Maryland.

Jeffrey Kang - Director - has a Doctor of Medicine from University of California, San Francisco and Master of Public Health from University of California, Berkeley.

Aditya Kohli - Venture Partner - a reçu un PhD in Bioengineering de University of California, San Francisco.

Robert Schueren - Chief Operating Officer - a reçu un American Course Drug and Regulatory Sciences Degree de University of California, San Francisco.

Rowan Chapman - Director - has a Postdoctoral Research, Biochemistry from University of California, San Francisco and Doctor of Philosophy in Biochemistry and Molecular Biology from University of Cambridge.

Patrick Smith - President of Integrated Drug Development - a reçu un Doctor of Pharmacy de University of California, San Francisco.

Joyce Tung - Vice President, Research - has a PhD in Genetics from University of California, San Francisco and Bachelor of Science in Biological Sciences from Stanford University.

Rowan Chapman - Director - has a Postdoctoral Research, Biochemistry from University of California, San Francisco and Doctor of Philosophy in Biochemistry and Molecular Biology from University of Cambridge.

Bill Martin - Global Therapeutic Head, Neuroscience - has a Postdoc, Neuroscience from University of California, San Francisco and PhD in Experimental Psychology from University of Maryland.

Sara Izadi - Chief Clinical Officer - a reçu un Doctor of Pharmacy de University of California, San Francisco.

Mark Demitrack - Senior Vice President and Chief Medical Officer - a reçu un Residency Training in Psychiatry de University of California, San Francisco.

Michael Drake - Chief Executive Officer, Europe and North America - a reçu un Doctor of Medicine in Ophthalmology de University of California, San Francisco.

Thomas Ciulla - Chief Medical Officer - a reçu un Medical Doctor de University of California, San Francisco.